Dietary Supplement Products was VitaNova Life Sciences’s largest product and service line in fiscal 2026, bringing in $1.95M of $3.03M (64%).
| Product and Service | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|
| Dietary Supplement Products | — | — | $2.65M | $1.95M |
| Sale Of Food Products | — | — | — | $1.06M |
| Sale Of Healthcare Products | — | $544.59K | — | — |
| Consultancy Service Fee Income | $38.00K | $26.10K | — | — |
| Consulting Service Income | — | — | $10.84K | $15.00K |
| Total | $38.00K | $570.69K | $2.66M | $3.03M |
VitaNova Life Sciences brought in $3.03M from its three product and service lines in fiscal 2026, the year ended April 30, 2026. VitaNova Life Sciences regrouped these lines after fiscal 2025, so the total does not compare directly with that year's $2.66M. Dietary Supplement Products was the largest at $1.95M (64.4%), ahead of Sale Of Food Products at $1.06M (35.1%) and Consulting Service Income at $15.00K (0.5%).
VitaNova Life Sciences began breaking out Dietary Supplement Products in fiscal 2025, Sale Of Food Products in fiscal 2026 and Consulting Service Income in fiscal 2025. VitaNova Life Sciences stopped reporting Sale Of Healthcare Products ($544.59K in fiscal 2024) and Consultancy Service Fee Income ($26.10K in fiscal 2024) as separate lines.
Dietary Supplement was VitaNova Life Sciences’s largest segment in fiscal 2026, bringing in $1.95M of $3.03M (64%).
| Segment | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|
| Dietary Supplement | — | — | $2.65M | $1.95M |
| Food Products | — | — | — | $1.06M |
| Healthcare | — | $544.59K | — | — |
| Consulting Service | $38.00K | $26.10K | $10.84K | — |
| Other | — | — | — | $15.00K |
| Total | $38.00K | $570.69K | $2.66M | $3.03M |
VitaNova Life Sciences brought in $3.03M from its three segments in fiscal 2026, the year ended April 30, 2026. VitaNova Life Sciences regrouped these segments after fiscal 2025, so the total does not compare directly with that year's $2.66M. Dietary Supplement was the largest at $1.95M (64.4%), ahead of Food Products at $1.06M (35.1%) and Other at $15.00K (0.5%).
VitaNova Life Sciences began breaking out Dietary Supplement in fiscal 2025, Food Products in fiscal 2026 and Other in fiscal 2026. VitaNova Life Sciences stopped reporting Healthcare ($544.59K in fiscal 2024) and Consulting Service ($10.84K in fiscal 2025) as separate segments.
Unites States Of America was VitaNova Life Sciences’s largest region in fiscal 2026, bringing in $2.68M of $3.03M (89%).
| Geography | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|
| Unites States Of America | $38.00K | $77.85K | $1.20M | $2.68M |
| Hong Kong | — | $81.75K | $1.07M | $345.58K |
| China | — | $411.10K | $385.72K | — |
| Total | $38.00K | $570.69K | $2.66M | $3.03M |
VitaNova Life Sciences brought in $3.03M from its two regions in fiscal 2026, the year ended April 30, 2026. VitaNova Life Sciences regrouped these regions after fiscal 2025, so the total does not compare directly with that year's $2.66M. Unites States Of America was the largest at $2.68M (88.6%), ahead of Hong Kong at $345.58K (11.4%).
Compared with fiscal 2025, Unites States Of America grew 122.6% to $2.68M, while Hong Kong fell 67.8% to $345.58K.
VitaNova Life Sciences began breaking out Hong Kong in fiscal 2024, when it brought in $81.75K. VitaNova Life Sciences stopped reporting China as a separate region after fiscal 2025, when it brought in $385.72K.
VitaNova Life Sciences (VNOV) reports its revenue by product and service, by segment and by geography. In fiscal 2026, Dietary Supplement Products was its largest product and service line, bringing in $1.95M (64.4% of the total), followed by Sale Of Food Products at $1.06M (35.1%).
Dietary Supplement Products was VitaNova Life Sciences' largest product and service line in fiscal 2026, bringing in $1.95M, or 64.4% of the $3.03M total across its three product and service lines.
Dietary Supplement was VitaNova Life Sciences' largest segment in fiscal 2026, bringing in $1.95M, or 64.4% of the $3.03M total across its three segments.
Unites States Of America was VitaNova Life Sciences' largest region in fiscal 2026, bringing in $2.68M, or 88.6% of the $3.03M total across its two regions.
Every figure comes from VitaNova Life Sciences' annual financial filings, as reported. Each line keeps the name VitaNova Life Sciences gives it, and years follow its fiscal calendar.
VitaNova Life Sciences' revenue by product and service goes back to fiscal 2023, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.